A drug underdevelopment may provide another pathway to lowering LDL levels.
Joseph E. Cruz, PharmD, BCPS
Advertisement
Articles by Joseph E. Cruz, PharmD, BCPS
Advertisement
Latest Updated Articles
- Targeting LDL via PCSK-9 from a Different Pathway
Published: July 12th 2017 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Pass-Through Rebate Law Uncovering New PBM Tactics, Entities | NCPA 2025
2
American Pharmacists Month: Expanding Services Through Dedicated Pharmacy Clinic
3
Automation Helps Pharmacies Maximize Revenue, Improve Patient Care | NCPA 2025
4
American Pharmacists Month: Pharmacist Champions Preventative Medicine Approach to Care
5
